Modulating P2X7 Receptor Signaling during Rheumatoid Arthritis: New Therapeutic Approaches for Bisphosphonates
P2X7 receptor-mediated purinergic signaling is a well-known mechanism involved in bone remodeling. The P2X7 receptor has been implicated in the pathophysiology of various bone and cartilage diseases, including rheumatoid arthritis (RA), a widespread and complex chronic inflammatory disorder. The P2X...
Saved in:
| Main Authors: | Alberto Baroja-Mazo, Pablo Pelegrín |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Journal of Osteoporosis |
| Online Access: | http://dx.doi.org/10.1155/2012/408242 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rheumatoid arthritis associated cytokines and therapeutics modulate immune checkpoint receptor expression on T cells
by: Dana Emerson, et al.
Published: (2025-02-01) -
Targeting the P2X7 receptor signaling pathway: Unlocking therapeutic strategies for autism spectrum disorder
by: Chetana Ahire, et al.
Published: (2025-08-01) -
The P2X7 receptor in depression: Novel insights and therapeutic implications
by: Yue-ting Zhong, et al.
Published: (2025-09-01) -
MAPK/ERK signaling pathway in rheumatoid arthritis: mechanisms and therapeutic potential
by: Jun Xie, et al.
Published: (2025-07-01) -
P2X7 receptors and multiple sclerosis: A potential biomarker and therapeutic target?
by: Cristina Agliardi, et al.
Published: (2026-01-01)